Navigation Links
DePuy ASR Hip Lawsuit News: New Case Substituted for Federal DePuy ASR Litigation’s First Bellwether Trial, Bernstein Liebhard LLP Reports

New York, New York (PRWEB) July 12, 2013

The U.S. District Judge presiding over thousands of DePuy ASR hip lawsuit claims filed in the U.S. District Court, Northern District of Ohio, has substituted a new case for the litigation’s first bellwether trial, Bernstein Liebhard LLP reports. According to an Order issued by Judge David A. Katz on July 8th, the opening date of the trial will remain September 9, 2013. Court documents indicate that the new bellwether case in the DePuy ASR litigation involves a Rochester, New York, patient who received one of the recalled implants in August 2009 and underwent revision surgery in January 2011. (McCracken v. DePuy Orthopaedics Inc., et al., No. 1:11-dp-2048)

“We look forward to the start of this trial in September. Many of the allegations made in this case echo those being put forth by our own DePuy ASR lawsuit clients,” says Bernstein Liebhard LLP, a nationwide law firm representing the victims of defective drugs and medical devices, including hundreds of clients in DePuy ASR lawsuits. The Firm continues to offer free legal evaluations to anyone who suffered serious complications associated with the DePuy ASR recall.

DePuy ASR Litigation
Court records indicate that more than 11,000 DePuy ASR lawsuits are pending in courts throughout the country, most of which have been filed in the multidistrict litigation being presided over by Judge Katz. All of the lawsuits allege the DePuy ASR, which was recalled in August 2010 due to an unacceptably high failure rate, was defectively designed and caused plaintiffs to suffer serious complications that resulted in early failure of the device, including metallosis, pain, and swelling. (In re: DePuy Orthopaedics, Inc. ASR Hip Implant Products Liability Litigation – MDL 2197)

While the trial in September will be the first in the federal litigation, two DePuy ASR lawsuit trials have already been held at the state level. In March, a plaintiff was awarded more than $8 million after a Los Angeles Superior Court jury found that the ASR was defectively designed. (Kransky v. DePuy, BC456086, California Superior Court, Los Angeles County) However, a jury in Chicago found for Johnson & Johnson in a second trial just one month later. (Strum v. DePuy, 2011-L-9352, Circuit Court of Cook County).

The DePuy ASR hip recall brought increased scrutiny on the entire class of metal-on-metal hips, and in February 2011, the U.S. Food & Drug Administration (FDA) began a safety review of such devices. In January 2013, the agency warned that metal-on-metal hips can shed dangerous amounts of metal debris in patients, leading to metallosis and other adverse local tissue reactions, pain and swelling, and ultimately premature failure of the device. The FDA has advised patients fitted with all-metal hips to undergo metal ion testing if they were experiencing signs or symptoms of device failure. The agency has also proposed new rules that would subject all-metal hips to greater regulatory oversight.*

Individuals affected by the DePuy ASR recall who allegedly suffered metallosis, premature device failure or other complications may be entitled to compensation for their medical bills, lost wages, pain and suffering, and other damages. A wealth of information regarding the DePuy ASR litigation is available on Bernstein Liebhard LLP’s website. For a free DePuy ASR lawsuit review, please contact one of our attorneys by calling 800-511-5092.

*, FDA, January 17, 2013

About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the “Plaintiffs’ Hot List,” recognizing the top plaintiffs’ firms in the country, for the past 10 consecutive years.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016

ATTORNEY ADVERTISING. © 2013 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information:
Felecia L. Stern, Esq.
Bernstein Liebhard LLP

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. DePuy Hip Replacement Lawsuit News: Lawsuit Chosen for First ASR Trial in Federal Court, Rottenstein Law Group LLP Reports
2. DePuy ASR Hip Recall News: Bernstein Liebhard LLP Comments on Irish Health Services Plan to Launch Major Review of Metal-on-Metal Hip Implants
3. DePuy ASR Lawsuits Progressing, Notes Rottenstein Law Group LLP
4. Arthrex, Depuy Mitek, and Smith & Nephew Lead the $1.5 Billion U.S. Orthopedic Soft Tissue Market, Reports iData Research
5. Bernstein Liebhard LLP Notes Plaintiffs’ Opposition to Defense Motion in Federal Litigation of DePuy Pinnacle Lawsuit Claims
6. US Drug Watchdog Now Calls Their DePuy Pinnacle Hip Implant Blood Test Initiative Vital And They Urge Recipients To Call Them For Instructions About This Important Test
7. US Drug Watchdog Now Urges All DePuy Pinnacle Hip Implant Recipients To Call Them For The Name Of A Special Blood Test To See If Their All Metal Hip Implant Has Failed
8. US Drug Watchdog Now Urges Recipients Of A DePuy Pinnacle All Metal Hip Implant To Call Them About A Vital Blood Test To See If Their Hip Implant Device Has Failed
9. DePuy Pinnacle Hip Replacement Lawsuit Filed by Wright & Schulte on Behalf of Ohio Man Who Required Revision Surgeries Allegedly Due to Pinnacle Hip Defects
10. DePuy ASR Hip Recall: Bernstein Liebhard LLP Comments on DePuy’s Motion to Strike Costs in Wake of $8.25 Million DePuy ASR Lawsuit Judgment
11. DePuy ASR Hip Implant Lawsuit Filed by Wright & Schulte on Behalf of Texas Man Who Alleges His Serious Hip Injuries Were Caused by Defective Design of ASR Hip Implant
Post Your Comments:
(Date:11/25/2015)... ... November 25, 2015 , ... Lakeview Health, ... country to celebrate their sobriety and show through pictures what a positive difference ... photos this Thanksgiving with the hashtag #FacesOfGratitude on their Facebook, Twitter, and Instagram ...
(Date:11/25/2015)... ... November 25, 2015 , ... On November 23rd 2015 Cozy Products, ... heating products business. Cozy Products explains what this means for business moving forward. , ... the Cozy Products business model: to sell personal heaters that reduce energy consumption, are ...
(Date:11/25/2015)... Livonia, MI (PRWEB) , ... November 25, 2015 , ... ... at Presence Resurrection Medical Center (RMC) in Chicago, IL, UV Angel is evaluating the ... the medical and surgical intensive care units (totaling 30 beds) from May 2014 through ...
(Date:11/25/2015)... ... November 25, 2015 , ... ... found that regular bras were incredibly uncomfortable," said an inventor from Bronx, N.Y. ... , She developed the patent-pending RECOVERY BRA for added comfort and support. The ...
(Date:11/25/2015)... ... , ... Since its launch in 2012, the Regenestem brand ... therapies to patients with chronic degenerative medical conditions. Now, the U.S. Patent and ... , Organizations are required to hold a registered trademark in order to make ...
Breaking Medicine News(10 mins):
(Date:11/24/2015)... 24, 2015  Thanks to a donor with a ... Medical Center,s Sister Diane Grassilli Center for Women,s Health ... San Francisco . ... forward with a gift of $617,320 that allowed the ... with Tomosynthesis and Whole Breast Ultrasound. Tomosynthesis, three-dimensional (3-D) ...
(Date:11/24/2015)... , Nov. 24, 2015  Array BioPharma Inc. ... Chief Executive Officer, Ron Squarer , will ... in New York.  The public is welcome to ... the Array BioPharma website.Event:Piper Jaffray Annual Healthcare ConferencePresenter:  ... December 2, 2015Time:1:30 p.m. Eastern Time Webcast: ...
(Date:11/24/2015)... Nov. 24, 2015 /PRNewswire/ - ESSA Pharma Inc. ("ESSA" ... announced today that the first patient has been enrolled ... a treatment for metastatic castration-resistant prostate cancer ("mCRPC"). ... --> the United States ... Phase 1/2 clinical trial, ESSA intends to demonstrate the ...
Breaking Medicine Technology: